Current and future clinical applications of zinc transporter-8 in type 1 diabetes mellitus

Chinese Medical Journal

Volumn 128, Issue 17, 2015, Pages 2387-2394

  Yi, Bo ^a   Huang, Gan ^a   Zhou, Zhi Guang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Autoantibodies; Autoimmunity; T cells; Type 1 diabetes mellitus; Zinc transporter 8

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; C PEPTIDE; EPITOPE; UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZINC TRANSPORTER 8; CATION TRANSPORT PROTEIN;

CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL TRIAL (TOPIC); HUMAN; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN SYNTHESIS; PANCREAS ISLET BETA CELL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; ZINC HOMEOSTASIS; ANIMAL; IMMUNOLOGY; METABOLISM;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; CATION TRANSPORT PROTEINS; DIABETES MELLITUS, TYPE 1; HUMANS;

EID: 84940184921     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.4103/0366-6999.163389     Document Type: Review

References (78)

1. International Diabetes Federation. IDF Diabetes Atlas. 6th ed. Brussels, Belgium: International Diabetes Federation; 2013
2. Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al.Prevalence and control of diabetes in Chinese adults. JAMA 2013;310:948-59
3. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al.Prevalence of diabetes among men and women in China. N Engl J Med 2010;362:1090-101
4. Zhou Z, Xiang Y, Ji L, Jia W, Ning G, Huang G, et al.Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): A nationwide, multicenter, clinic-based cross-sectional study. Diabetes 2013;62:543-50
5. In’t Veld P. Insulitis in human type 1 diabetes: A comparison between patients and animal models. Semin Immunopathol 2014;36:569-79
6. Coppieters KT, Dotta F, Amirian N, Campbell PD, Kay TW, Atkinson MA, et al.Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med 2012;209:51-60
7. Arvan P, Pietropaolo M, Ostrov D, Rhodes CJ. Islet autoantigens: Structure, function, localization, and regulation. Cold Spring Harb Perspect Med 2012;2:a007658
8. Di Gialleonardo V, de Vries EF, Di Girolamo M, Quintero AM, Dierckx RA, Signore A. Imaging of ß-cell mass and insulitis in insulin-dependent (Type 1) diabetes mellitus. Endocr Rev 2012;33:892-919
9. Mallone R, Roep BO. Biomarkers for immune intervention trials in type 1 diabetes. Clin Immunol 2013;149:286-96
10. Winter WE, Schatz DA. Autoimmune markers in diabetes. Clin Chem 2011;57:168-75
11. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, et al.The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 2007;104:17040-5
12. Ziegler AG, Nepom GT. Prediction and pathogenesis in type 1 diabetes. Immunity 2010;32:468-78
13. Chujo D, Foucat E, Nguyen TS, Chaussabel D, Banchereau J, Ueno H. ZnT8-Specific CD4+ T cells display distinct cytokine expression profiles between type 1 diabetes patients and healthy adults. PLoS One 2013;8:e55595
14. Dang M, Rockell J, Wagner R, Wenzlau JM, Yu L, Hutton JC, et al.Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8. J Immunol 2011;186:6056-63
15. Énée É, Kratzer R, Arnoux JB, Barilleau E, Hamel Y, Marchi C, et al.ZnT8 is a major CD8+T cell-recognized autoantigen in pediatric type 1 diabetes. Diabetes 2012;61:1779-84
16. Mallone R, Brezar V, Boitard C. T cell recognition of autoantigens in human type 1 diabetes: Clinical perspectives. Clin Dev Immunol 2011;2011:513210
17. Nakayama M, Abiru N, Moriyama H, Babaya N, Liu E, Miao D, et al.Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 2005;435:220-3
18. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, et al.A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007;445:881-5
19. Gohlke H, Ferrari U, Koczwara K, Bonifacio E, Illig T, Ziegler AG. SLC30A8 (ZnT8) polymorphism is associated with young age at type 1 diabetes onset. Rev Diabet Stud 2008;5:25-7
20. Xu K, Zha M, Wu X, Yu Z, Yu R, Xu X, et al.Association between rs13266634 C/T polymorphisms of solute carrier family 30 member 8 (SLC30A8) and type 2 diabetes, impaired glucose tolerance, type 1 diabetes – a meta-analysis. Diabetes Res Clin Pract 2011;91:195-202
21. Achenbach P, Lampasona V, Landherr U, Koczwara K, Krause S, Grallert H, et al.Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia 2009;52:1881-8
22. Flannick J, Thorleifsson G, Beer NL, Jacobs SB, Grarup N, Burtt NP, et al.Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nat Genet 2014;46:357-63
23. Pound LD, Hang Y, Sarkar SA, Wang Y, Milam LA, Oeser JK, et al.The pancreatic islet ß-cell-enriched transcription factor Pdx-1 regulates Slc30a8 gene transcription through an intronic enhancer. Biochem J 2011;433:95-105
24. Egefjord L, Jensen JL, Bang-Berthelsen CH, Petersen AB, Smidt K, Schmitz O, et al.Zinc transporter gene expression is regulated by pro-inflammatory cytokines: A potential role for zinc transporters in beta-cell apoptosis? BMC Endocr Disord 2009;9:7
25. El Muayed M, Billings LK, Raja MR, Zhang X, Park PJ, Newman MV, et al.Acute cytokine-mediated downregulation of the zinc transporter ZnT8 alters pancreatic beta-cell function. J Endocrinol 2010;206:159-69
26. Smidt K, Jessen N, Petersen AB, Larsen A, Magnusson N, Jeppesen JB, et al.SLC30A3 responds to glucose- and zinc variations in beta-cells and is critical for insulin production and in vivo glucose-metabolism during beta-cell stress. PLoS One 2009;4:e5684
27. Kawasaki E. ZnT8 and type 1 diabetes. Endocr J 2012;59:531-7
28. Davidson HW, Wenzlau JM, O’Brien RM. Zinc transporter 8 (ZnT8) and ß cell function. Trends Endocrinol Metab 2014;25:415-24
29. Lampasona V, Petrone A, Tiberti C, Capizzi M, Spoletini M, di Pietro S, et al.Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4. Diabetes Care 2010;33:104-8
30. Skärstrand H, Lernmark A, Vaziri-Sani F. Antigenicity and epitope specificity of ZnT8 autoantibodies in type 1 diabetes. Scand J Immunol 2013;77:21-9
31. Wenzlau JM, Frisch LM, Hutton JC, Davidson HW. Mapping of conformational autoantibody epitopes in ZNT8. Diabetes Metab Res Rev 2011;27:883-6
32. Wenzlau JM, Liu Y, Yu L, Moua O, Fowler KT, Rangasamy S, et al.A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes. Diabetes 2008;57:2693-7
33. Wenzlau JM, Moua O, Liu Y, Eisenbarth GS, Hutton JC, Davidson HW. Identification of a major humoral epitope in Slc30A8 (ZnT8). Ann N Y Acad Sci 2008;1150:252-5
34. Kawasaki E, Uga M, Nakamura K, Kuriya G, Satoh T, Fujishima K, et al.Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes. Diabetologia 2008;51:2299-302
35. Vaziri-Sani F, Delli AJ, Elding-Larsson H, Lindblad B, Carlsson A, Forsander G, et al.A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes. J Immunol Methods 2011;371:25-37
36. Chang KY, Unanue ER. Prediction of HLA-DQ8beta cell peptidome using a computational program and its relationship to autoreactive T cells. Int Immunol 2009;21:705-13
37. Nayak DK, Calderon B, Vomund AN, Unanue ER. ZnT8-reactive T cells are weakly pathogenic in NOD mice but can participate in diabetes under inflammatory conditions. Diabetes 2014;63:3438-48
38. Scotto M, Afonso G, Larger E, Raverdy C, Lemonnier FA, Carel JC, et al.Zinc transporter (ZnT) 8 (186-194) is an immunodominant CD8+T cell epitope in HLA-A2+type 1 diabetic patients. Diabetologia 2012;55:2026-31
39. Wu X, Xu X, Gu R, Wang Z, Chen H, Xu K, et al.Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays. Autoimmunity 2012;45:176-85
40. Li S, Li H, Chen B, Lu D, Deng W, Jiang Y, et al.Identification of novel HLA-A 0201-restricted cytotoxic T lymphocyte epitopes from Zinc Transporter 8. Vaccine 2013;31:1610-5
41. Rolandsson O, Palmer JP. Latent autoimmune diabetes in adults (LADA) is dead: Long live autoimmune diabetes! Diabetologia 2010;53:1250-3
42. Sanjeevi CB, Schatz DA, Atkinson MA. The IDS conducts standardization of assays for the measurement of autoantibodies and of T cells in autoimmune diabetes. Preface. Ann N Y Acad Sci 2008;1150:xiii
43. Trabucchi A, Faccinetti NI, Guerra LL, Puchulu FM, Frechtel GD, Poskus E, et al.Detection and characterization of ZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype. Autoimmunity 2012;45:137-42
44. Ziegler AG, Bonifacio E, BABYDIAB-BABYDIET Study Group. Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes. Diabetologia 2012;55:1937-43
45. Parikka V, Näntö-Salonen K, Saarinen M, Simell T, Ilonen J, Hyöty H, et al.Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk. Diabetologia 2012;55:1926-36
46. Vaziri-Sani F, Oak S, Radtke J, Lernmark K, Lynch K, Agardh CD, et al.ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset. Autoimmunity 2010;43:598-606
47. Wenzlau JM, Walter M, Gardner TJ, Frisch LM, Yu L, Eisenbarth GS, et al.Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects. J Clin Endocrinol Metab 2010;95:4712-9
48. Petruzelkova L, Ananieva-Jordanova R, Vcelakova J, Vesely Z, Stechova K, Lebl J, et al.The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus. Diabet Med 2014;31:165-71
49. Richardson CC, Dromey JA, McLaughlin KA, Morgan D, Bodansky HJ, Feltbower RG, et al. High frequency of autoantibodies in patients with long duration type 1 diabetes. Diabetologia 2013;56:2538-40
50. Andersson C, Larsson K, Vaziri-Sani F, Lynch K, Carlsson A, Cedervall E, et al.The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes. Autoimmunity 2011;44:394-405
51. Yang L, Luo S, Huang G, Peng J, Li X, Yan X, et al.The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese. Diabetes Metab Res Rev 2010;26:579-84
52. Kawasaki E, Nakamura K, Kuriya G, Satoh T, Kobayashi M, Kuwahara H, et al.Zinc transporter 8 autoantibodies in fulminant, acute-onset, and slow-onset patients with type 1 diabetes. Diabetes Metab Res Rev 2011;27:895-8
53. Kawasaki E, Nakamura K, Kuriya G, Satoh T, Kobayashi M, Kuwahara H, et al.Differences in the humoral autoreactivity to zinc transporter 8 between childhood- and adult-onset type 1 diabetes in Japanese patients. Clin Immunol 2011;138:146-53
54. Huang G, Xiang Y, Pan L, Li X, Luo S, Zhou Z. Zinc transporter 8 autoantibody (ZnT8A) could help differentiate latent autoimmune diabetes in adults (LADA) from phenotypic type 2 diabetes mellitus. Diabetes Metab Res Rev 2013;29:363-8
55. Luo S, Zhang Z, Li X, Yang L, Lin J, Yan X, et al.Fulminant type 1 diabetes: A collaborative clinical cases investigation in China. Acta Diabetol 2013;50:53-9
56. Andersen MK, Härkönen T, Forsblom C, Groop PH, Knip M, Tuomi T. Zinc transporter type 8 autoantibodies (ZnT8A): Prevalence and phenotypic associations in latent autoimmune diabetes patients and patients with adult onset type 1 diabetes. Autoimmunity 2013;46:251-8
57. Sørgjerd EP, Skorpen F, Kvaløy K, Midthjell K, Grill V. Prevalence of ZnT8 antibody in relation to phenotype and SLC30A8 polymorphism in adult autoimmune diabetes: Results from the HUNT study, Norway. Autoimmunity 2013;46:74-9
58. Yu L, Boulware DC, Beam CA, Hutton JC, Wenzlau JM, Greenbaum CJ, et al.Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies. Diabetes Care 2012;35:1213-8
59. De Grijse J, Asanghanwa M, Nouthe B, Albrecher N, Goubert P, Vermeulen I, et al.Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: Implications for prevention trials. Diabetologia 2010;53:517-24
60. Vermeulen I, Weets I, Asanghanwa M, Ruige J, Van Gaal L, Mathieu C, et al.Contribution of antibodies against IA-2ß and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age. Diabetes Care 2011;34:1760-5
61. Andersson C, Vaziri-Sani F, Delli A, Lindblad B, Carlsson A, Forsander G, et al.Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes. Pediatr Diabetes 2013;14:97-105
62. Ingemansson S, Vaziri-Sani F, Lindblad U, Gudbjornsdottir S, Törn C, Diss-Study Group. Long-term sustained autoimmune response to beta cell specific zinc transporter (ZnT8, W, R, Q) in young adult patients with preserved beta cell function at diagnosis of diabetes. Autoimmunity 2013;46:50-61
63. Gorus FK, Balti EV, Vermeulen I, Demeester S, Van Dalem A, Costa O, et al.Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: A cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients. Clin Exp Immunol 2013;171:82-90
64. Delli AJ, Vaziri-Sani F, Lindblad B, Elding-Larsson H, Carlsson A, Forsander G, et al.Zinc transporter 8 autoantibodies and their association with SLC30A8 and HLA-DQ genes differ between immigrant and Swedish patients with newly diagnosed type 1 diabetes in the Better Diabetes Diagnosis study. Diabetes 2012;61:2556-64
65. Borg H, Gottsäter A, Landin-Olsson M, Fernlund P, Sundkvist G. High levels of antigen-specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age. J Clin Endocrinol Metab 2001;86:3032-8
66. Liu L, Li X, Xiang Y, Huang G, Lin J, Yang L, et al.Latent autoimmune diabetes in adults with low-titer GAD antibodies: Similar disease progression with type 2 diabetes: A nationwide, multicenter prospective study (LADA China Study 3). Diabetes Care 2015;38:16-21
67. Hameed S, Ellard S, Woodhead HJ, Neville KA, Walker JL, Craig ME, et al.Persistently autoantibody negative (PAN) type 1 diabetes mellitus in children. Pediatr Diabetes 2011;12:142-9
68. Kawasaki E, Nakamura K, Kuriya G, Satoh T, Kuwahara H, Kobayashi M, et al.Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes. J Clin Endocrinol Metab 2010;95:707-13
69. Andersen ML, Vaziri-Sani F, Delli A, Pörksen S, Jacobssen E, Thomsen J, et al.Association between autoantibodies to the Arginine variant of the Zinc transporter 8 (ZnT8) and stimulated C-peptide levels in Danish children and adolescents with newly diagnosed type 1 diabetes. Pediatr Diabetes 2012;13:454-62
70. Nielsen LB, Vaziri-Sani F, Pörksen S, Andersen ML, Svensson J, Bergholdt R, et al.Relationship between ZnT8Ab, the SLC30A8 gene and disease progression in children with newly diagnosed type 1 diabetes. Autoimmunity 2011;44:616-23
71. Sorensen JS, Vaziri-Sani F, Maziarz M, Kristensen K, Ellerman A, Breslow N, et al.Islet autoantibodies and residual beta cell function in type 1 diabetes children followed for 3-6 years. Diabetes Res Clin Pract 2012;96:204-10
72. Moosavi M, Séguin J, Li Q, Polychronakos C. The effect of type 2 diabetes risk loci on insulin requirements in type 1 diabetes. Horm Res Paediatr 2012;77:305-8
73. Lernmark A, Larsson HE. Immune therapy in type 1 diabetes mellitus. Nat Rev Endocrinol 2013;9:92-103
74. Yu L, Herold K, Krause-Steinrauf H, McGee PL, Bundy B, Pugliese A, et al.Rituximab selectively suppresses specific islet antibodies. Diabetes 2011;60:2560-5
75. Bonaventura P, Benedetti G, Albarède F, Miossec P. Zinc and its role in immunity and inflammation. Autoimmun Rev 2015;14:277-85
76. Masala S, Paccagnini D, Cossu D, Brezar V, Pacifico A, Ahmed N, et al.Antibodies recognizing Mycobacterium avium paratuberculosis epitopes cross-react with the beta-cell antigen ZnT8 in Sardinian type 1 diabetic patients. PLoS One 2011;6:e26931
77. Pearson E. Zinc transport and diabetes risk. Nat Genet 2014;46:323-4
78. Capdor J, Foster M, Petocz P, Samman S. Zinc and glycemic control: A meta-analysis of randomised placebo controlled supplementation trials in humans. J Trace Elem Med Biol 2013;27:137-42.